What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.11%Above 5Y avg (0.77%)
Annual Rate
CNY 0.09Paid annual
Payout Ratio
70.3%Moderate
Payback Period
90.1 yr
Last Ex-Dividend
Jun 3, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.96BCNY
735.70M · vs all stocks (USD)
Updated Aug 19, 2026
Trailing P/E
76.60x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Revenue (TTM)
1.80BCNY
267.34M · vs all stocks (USD)
Updated Aug 19, 2026
Profit Margin
3.54%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Beta
0.4860x
vs all stocks
Updated Aug 19, 2026
52-Week Change
-35.09%
vs all stocks
Updated Aug 19, 2026
Market Capitalization
4.96BCNY
735.70M · vs all stocks (USD)
Updated Aug 19, 2026
Enterprise Value
4.76BCNY
705.28M · vs all stocks (USD)
Updated Aug 19, 2026
Trailing P/E
76.60x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Forward P/E
24.71x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Price to Sales (TTM)
2.73x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Price to Book (MRQ)
2.05x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Enterprise to Revenue
2.64x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Enterprise to EBITDA
35.12x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 38.7×.Updated Aug 19, 2026
Gross Margin
37.01%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Profit Margin
3.54%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Operating Margin
0.06%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Return on Assets (TTM)
1.21%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Return on Equity (TTM)
2.55%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Revenue (TTM)
1.80BCNY
267.34M · vs all stocks (USD)
Updated Aug 19, 2026
Revenue per Share (TTM)
2.82CNYUpdated Aug 19, 2026
Quarterly Revenue Growth
19.30%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Gross Profit (TTM)
685.48MCNY
101.66M · vs all stocks (USD)
Updated Aug 19, 2026
EBITDA (TTM)
122.90MCNY
18.23M · vs all stocks (USD)
Updated Aug 19, 2026
Net Income (TTM)
63.84MCNY
9.47M · vs all stocks (USD)
Updated Aug 19, 2026
Quarterly Earnings Growth (YoY)
16.90%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Operating Cash Flow (TTM)
497.97MCNY
73.85M · vs all stocks (USD)
Updated Aug 19, 2026
Levered Free Cash Flow (TTM)
446.19MCNY
66.17M · vs all stocks (USD)
Updated Aug 19, 2026
Trailing Annual Dividend Rate
0.0850CNYUpdated Aug 19, 2026
Trailing Annual Dividend Yield
1.11%
vs all stocks
Updated Aug 19, 2026
5-Year Average Dividend Yield
0.77%
vs all stocks
Updated Aug 19, 2026
Payout Ratio
70.28%
vs Scientific & Technical Instruments peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 85%.Updated Aug 19, 2026
Minority Interest (Equity)
123.43MCNYFY2025 · Dec 31, 2025
Revenue
1.74BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
1.05BCNYFY2025 · Dec 31, 2025
Gross Profit
691.13MCNYFY2025 · Dec 31, 2025
Operating Income
123.80MCNY
18.36M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
78.48MCNYFY2025 · Dec 31, 2025
Income Tax Expense
13.57MCNYFY2025 · Dec 31, 2025
Net Income
64.91MCNYFY2025 · Dec 31, 2025
EBIT
101.81MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
387.13MCNYFY2025 · Dec 31, 2025
Research & Development
119.20MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
84.34MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
16.31MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
3.63MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
23.34MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.0995CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.0992CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
638.94MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
638.94MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
64.91MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-1.33MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
147.47MCNYFY2025 · Dec 31, 2025
Free Cash Flow
73.07MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
824.18MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
64.91MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
48.83MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
77.93MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-44.19MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-74.40MCNYFY2025 · Dec 31, 2025
Net Acquisitions
470.00KCNYFY2025 · Dec 31, 2025
Purchase of Investments
0.00CNYFY2025 · Dec 31, 2025
Sale of Investments
13.34MCNYFY2025 · Dec 31, 2025
Other Investing Activity
74.94MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
14.35MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
0.00CNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-24.15MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-50.86MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-91.26MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-166.27MCNYFY2025 · Dec 31, 2025
Shares Outstanding
643.44MSharesUpdated Aug 19, 2026
Float Shares
320.14MSharesUpdated Aug 19, 2026
% Held by Insiders
51.42%
vs all stocks
Updated Aug 19, 2026
% Held by Institutions
9.17%
vs all stocks
Updated Aug 19, 2026
Total Cash (MRQ)
845.89MCNY
125.45M · vs all stocks (USD)
Updated Aug 19, 2026
Total Cash per Share (MRQ)
1.31CNYUpdated Aug 19, 2026
Total Debt (MRQ)
519.13MCNY
76.99M · vs all stocks (USD)
Updated Aug 19, 2026
Total Debt to Equity (MRQ)
0.2059x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Current Ratio (MRQ)
1.78x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Book Value per Share (MRQ)
3.73CNYUpdated Aug 19, 2026
Total Assets
4.14BCNY
614.50M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.95BCNYFY2025 · Dec 31, 2025
Total Liabilities
1.62BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
2.20BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
441.45MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
1.18BCNYFY2025 · Dec 31, 2025
Cash
819.39MCNYFY2025 · Dec 31, 2025
Cash Equivalents
113.67MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
933.06MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
315.87KCNYFY2025 · Dec 31, 2025
Accounts Receivable
377.28MCNYFY2025 · Dec 31, 2025
Inventory
452.64MCNYFY2025 · Dec 31, 2025
Accounts Payable
250.02MCNYFY2025 · Dec 31, 2025
Short-term Debt
277.60MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
23.38MCNYFY2025 · Dec 31, 2025
Long-term Debt
397.27MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
14.98MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
643.44MCNYFY2025 · Dec 31, 2025
Retained Earnings
625.21MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
2.52BCNY
373.93M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
25.49MCNYFY2025 · Dec 31, 2025
52-Week Low
6.98CNYUpdated Aug 19, 2026
52-Week High
12.30CNYUpdated Aug 19, 2026
52-Week Change
-35.09%
vs all stocks
Updated Aug 19, 2026
Beta
0.4860x
vs all stocks
Updated Aug 19, 2026
50-Day MA
7.53CNYUpdated Aug 19, 2026
200-Day MA
8.78CNYUpdated Aug 19, 2026
Avg 10-Day Volume
4.90MSharesUpdated Aug 19, 2026
Avg 30-Day Volume
5.95MSharesUpdated Aug 19, 2026
Diluted EPS (TTM)
0.1000CNYUpdated Aug 19, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.